PO-679-05 DIFFERENCES IN ATRIAL FIBRILLATION CRYOBALLOON ABLATION BY GENDER: 24-MONTH OUTCOMES FROM THE CRYO AF GLOBAL REGISTRY

Surinder Kaur Khelae(National Heart Institute), Csaba Földesi(Gottsegen National Cardiovascular Center), K. R. Julian Chun(Cardiovascular Center Bethanien), Fred Kueffer(Medtronic (United States)), Christian Drephal(Sana Klinikum Lichtenberg), Kelly A. van Bragt(Medtronic (United States)), Paweł Ptaszyński(Medical University of Lodz), Derick Todd(University of Liverpool), Fernando Scazzuso(Instituto Cardiovascular de Buenos Aires), Thorsten Lawrenz(Klinikum Bielefeld)
Heart Rhythm
April 28, 2022
10.1016/j.hrthm.2022.03.489
Cited by 1

Related Papers

Effect of Renal Denervation and Catheter Ablation vs Catheter Ablation Alone on Atrial Fibrillation Recurrence Among Patients With Paroxysmal Atrial Fibrillation and Hypertension
|JAMA|2020|232
Cryoballoon ablation of pulmonary veins for persistent atrial fibrillation: Results from the multicenter STOP Persistent AF trial
|Heart Rhythm|2020|162
Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy
|EP Europace|2012|107
Quantitative Assessment of Microvolt T‐Wave Alternans in Patients with Congestive Heart Failure
|Journal of Cardiovascular Electrophysiology|2005|84
Practical considerations, indications, and future perspectives for leadless and extravascular cardiac implantable electronic devices: a position paper by EHRA/HRS/LAHRS/APHRS
|EP Europace|2022|69